COMMUNIQUÉS West-GlobeNewswire

Vital Nutrients Expands Clinical Line With New Formula for Women’s Hair Health
01/10/2025
MIDDLETOWN, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- With female hair loss on the rise, Vital Nutrients is introducing Hair Growth Complex for Women , a clinically formulated supplement targeting the biological drivers [...]
POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer's Immunotherapy
01/10/2025
Innovative 'Mosaic' Active Immunotherapy to Target Alzheimer's Disease Buffalo, NY , Oct. 01, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies, Inc. (POP BIO) , has been awarded a $2.46M USD grant by the National Institutes [...]
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
01/10/2025
WALTHAM, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF [...]
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025
CHARLESTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]
George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
01/10/2025
MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Artelo Biosciences Announces Closing of $2.0 Million Public Offering
01/10/2025
SOLANA BEACH, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
01/10/2025
CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
01/10/2025
Initial clinical data for BDC-4182 Phase 1 dose escalation study now expected in 3Q 2026 Company is implementing a 50% workforce reduction to extend cash runway into 2027 REDWOOD CITY, Calif., Oct. 01, 2025 (GLOBE [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted seven newly [...]
Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025
01/10/2025
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025 [...]
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare [...]
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business
01/10/2025
Mechelen, Belgium ; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement: On May 13, 2025, Galapagos announced that its Board of [...]
Boyce Thompson Institute Launches the Jane Silverthorne Postdoctoral Fellowship Program
01/10/2025
Now accepting applications to support high-risk, high-reward research at the frontiers of plant science A message from Silvia Restrepo, President, Boyce Thompson Institute Ithaca, NY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- [...]
Comfort Keepers Ireland Unveils Study Forecasting Doubling of Homecare Demand by 2057
01/10/2025
Ireland’s Ageing Population Will Double Homecare Needs - Data Highlights Planning Required Dublin, Leinster , Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comfort Keepers Ireland today unveiled a new study highlighting the country [...]
EssilorLuxottica completes acquisition of Optegra
01/10/2025
EssilorLuxottica completes acquisition of Optegra Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the acquisition of Optegra from MidEuropa. Under the Optegra, Lexum and [...]
EssilorLuxottica finalise l’acquisition d’Optegra
01/10/2025
EssilorLuxottica finalise l’acquisition d’Optegra Paris, France (1 er octobre 2025) – EssilorLuxottica annonce la finalisation de l’acquisition d’Optegra auprès de MidEuropa. Avec les marques Optegra, Lexum et Iris, [...]
The Facial Pain Association (FPA) Highlights Trigeminal Neuralgia and the Facial Pain Community during Facial Pain Awareness Month
01/10/2025
Buildings and monuments around the world light up teal to show support. Awareness Month activities also highlight patient stories, educational resources, and the launch of the new Facial Pain Registry SUWANEE, Ga., Oct [...]
Cirtec Medical Appoints Steven Chevillotte to its Board of Directors
01/10/2025
BROOKLYN PARK, Minn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a global leader in design, development, and manufacturing of complex Class II and III medical devices, is pleased to announce that Steven [...]
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
01/10/2025
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its [...]

Pages